Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $195,709 | 89 | 99.9% |
| Food and Beverage | $124.93 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $180,434 | 81 | $0 (2024) |
| Shire North American Group Inc | $15,275 | 8 | $0 (2019) |
| PFIZER INC. | $91.41 | 6 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $33.52 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,683 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($57,683) |
| 2023 | $40,267 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($40,267) |
| 2022 | $31,850 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($31,850) |
| 2021 | $24,712 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($24,633) |
| 2020 | $26,000 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($26,000) |
| 2019 | $15,288 | 9 | Shire North American Group Inc ($15,275) |
| 2018 | $10.87 | 1 | PFIZER INC. ($10.87) |
| 2017 | $22.17 | 2 | PFIZER INC. ($11.56) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $591.67 | General |
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $591.67 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,366.67 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 127 | 128 | $69,844 | $17,281 |
| 2022 | 3 | 419 | 436 | $233,882 | $61,687 |
| 2021 | 3 | 383 | 388 | $206,462 | $55,759 |
| 2020 | 4 | 464 | 481 | $253,302 | $70,006 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 95 | 95 | $49,780 | $12,807 | 25.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 18 | $14,724 | $3,056 | 20.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 15 | 15 | $5,340 | $1,418 | 26.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 359 | 372 | $194,928 | $52,719 | 27.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 33 | 35 | $28,630 | $6,219 | 21.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 27 | 29 | $10,324 | $2,748 | 26.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 290 | 294 | $154,056 | $43,561 | 28.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 41 | 41 | $33,538 | $7,541 | 22.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 52 | 53 | $18,868 | $4,657 | 24.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 367 | 382 | $200,168 | $57,315 | 28.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 42 | 43 | $35,174 | $7,823 | 22.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 42 | 43 | $15,308 | $4,228 | 27.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 13 | 13 | $2,652 | $638.92 | 24.1% |
About Dr. Bradley Houts, MD
Dr. Bradley Houts, MD is a Emergency Medicine healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881688299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Houts, MD has received a total of $195,833 in payments from pharmaceutical and medical device companies, with $57,683 received in 2024. These payments were reported across 97 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($195,709).
As a Medicare-enrolled provider, Houts has provided services to 1,393 Medicare beneficiaries, totaling 1,433 services with total Medicare billing of $204,732. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location North Kansas City, MO
- Active Since 08/31/2005
- Last Updated 02/24/2014
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1881688299
Products in Payments
- ELIQUIS (Drug) $124.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in North Kansas City
Dr. Jack Stauffer, Md, MD
Emergency Medicine — Payments: $2,256
Dr. Jason Graham, Md, MD
Emergency Medicine — Payments: $356.83
Dr. Clifford Weith, Do, DO
Emergency Medicine — Payments: $316.34
Dr. Steven Russell, Md, MD
Emergency Medicine — Payments: $246.89
David Brewer, D.o, D.O
Emergency Medicine — Payments: $221.46
Dr. Leland Robinson, Md, MD
Emergency Medicine — Payments: $195.50